Here’s How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years

Edwards Lifesciences (NYSE: EW) generated an average annual return of 17.22% over the past 20 years, according to Benzinga data published August 19, 2026. The result exceeded the market’s performance by 7.93% on an annualized basis. For investors focused on compounding, the historical outcome is significant. A $100 investment in EW made 20 years ago would be worth $2,380.52 today, based on a share price of $91.03 at the time of writing. The calculation demonstrates how sustained annual returns can transform a relatively small initial investment over a long holding period. It also highlights why investment outcomes are shaped not only by annual performance, but by the length of time capital remains invested and the reinvestment of gains. Edwards Lifesciences currently has a market capitalization of $52.47 billion. Its 20-year performance was notable both for its absolute return and for its ability to outperform the broader market over an extended period. Investors should distinguish historical performance from future expectations. The reported figures describe what EW delivered during the preceding two decades; future returns will depend on the company’s operating results, valuation and broader market conditions. Past performance does not guarantee future results, and the figures are not investment advice. The central takeaway is the power of compounded returns. In this example, Edwards Lifesciences converted $100 into $2,380.52 based on the stated historical performance and price, underscoring the potential impact of long-term equity ownership.